Specifically, in pancreatic cancer, Smad4 serves as a tumor suppressor by inhibiting epithelial cell proliferation, and its loss can lead to tumor-promoting effects, illustrating the dual role of TGF-β in this malignancy [7]. Here, SMAD4 is linked to familial pancreatic carcinoma.